Centene Corporation
$63.76
▲ +2.48%
+$1.54
NYSE · Healthcare · Healthcare Plans
· price updated 9h ago
CNC · NYSE · Healthcare · Healthcare Plans · price updated 9h ago
$63.76
▲ +2.48% · +$1.54 today
AI research · $63.76
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Favorable · 18% below Sector avg · favorable
13.50x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
0.17x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
3.43x
EV / EBITDA
Operating value including debt
No signal · Not enough data to judge
-
Quality
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
8.8%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-20.4%
Debt / equity
Balance-sheet leverage
Middle ground · Roughly in line with sector
0.71x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.15x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $30.74B | - | +13.9% | 63 | |
| $10.69B | 18.4 | +23.5% | 78 | |
| $4.88B | 20.3 | +10.3% | 77 | |
| $31.49B | 32.9 | +15.5% | 77 | |
| $1.08T | 41.4 | +47.4% | 76 |
US stock research
Centene Corporation — US core universe (S&P 500 sourced). CNC was +2.5% in the latest available session at $63.76. Its reported market value was $30.74B with a trailing P/E of 0.0. Latest reported revenue was $202.94B, changing +13.9% year over year, with $-5.10B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.